UPDATE: Morgan Stanley Lowering Price Target on MetLife
Morgan Stanley is out with a research report on MetLife (NYSE: MET) and it has an Overweight rating on shares, but is lowering its price target to $47 from $53.
Shares of MET gained 18 cents yesterday to close at $30.58.







